Halaven (eribulin) demonstrates overall survival benefit in rare soft tissue sarcoma

[News]

Phase III data show Halaven® (eribulin) offers a significant overall survival benefit in people with advanced leiomyosarcoma (LMS) and adipocytic sarcoma (liposarcomas)1 compared to dacarbazine...

More... (http://www.medicalnewstoday.com/releases/300890.php)